Allogeneic ‘off‐the‐shelf’ <scp>SARS</scp>‐<scp>C</scp>o<scp>V</scp>‐2‐specific adoptive T‐cell therapy for refractory viral infection and end organ diseaseAndrea Henden, Corey Smith, Archana Panikkar et al.|Clinical & Translational Immunology|2025Cited by 1